SCHEDULE: Goldman Sachs Discloses 5.2% Stake in Indivior PLC

The Goldman Sachs Group, Inc. and its subsidiary, Goldman Sachs & Co. LLC, reported a 5.2% beneficial ownership stake in Indivior PLC as of September 30, 2025.

Summary

• The Goldman Sachs Group, Inc. and its subsidiary, Goldman Sachs & Co. LLC, jointly reported beneficial ownership of 6,531,868.75 ordinary shares of Indivior PLC.
• This ownership represents 5.2% of Indivior PLC's outstanding ordinary shares.
• The shares are held in the ordinary course of business and not for the purpose of changing or influencing control of Indivior PLC.
• Goldman Sachs & Co. LLC, a registered broker-dealer and investment adviser, holds these securities as a subsidiary of The Goldman Sachs Group, Inc.
• The reporting persons have shared voting power over 6,531,833.75 shares and shared dispositive power over 6,531,868.75 shares, with no sole voting or dispositive power.

Sentiment

Score: 6

Explanation: The filing indicates a substantial beneficial ownership stake by Goldman Sachs in Indivior PLC, which can be interpreted as a vote of confidence from a major financial institution. The stated purpose of the holding is for ordinary course of business, not control, suggesting a passive investment.

Positives

• A significant institutional investor, Goldman Sachs, holds a 5.2% stake, indicating confidence or strategic interest in Indivior PLC.
• The holding is stated to be in the ordinary course of business, not for control purposes, suggesting a passive investment.

Future Outlook

NA

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §§ 240.14a-11."

Industry Context

This filing indicates a significant institutional investment in Indivior PLC, a pharmaceutical company. Such investments by major financial institutions like Goldman Sachs can signal market confidence in the company's sector or specific business strategy, potentially influencing other investors.

Stakeholder Impact

• Shareholders: May view Goldman Sachs' 5.2% stake as a positive signal, potentially increasing investor confidence and demand for Indivior PLC shares.
• Management: The presence of a significant institutional investor may lead to increased scrutiny or engagement, though the filing states the holding is not for influencing control.

Key Dates

Recommendation

The filing reveals a significant 5.2% beneficial ownership by Goldman Sachs in Indivior PLC. While this indicates institutional interest and can be a positive signal, a Schedule 13G filing primarily reports ownership and does not provide sufficient financial or operational details to warrant a 'buy' or 'sell' recommendation. It suggests a 'hold' position, acknowledging the institutional confidence while awaiting further fundamental analysis of Indivior PLC's performance and strategic direction.

Keywords

Indivior PLC, Goldman Sachs, Beneficial Ownership, Schedule 13G, Institutional Investment, Ordinary Shares, Equity Stake, SEC Filing